Completed PHASE2/PHASE3 INTERVENTIONAL 5-arm NCT02147639

Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy

Sponsor: Cedars-Sinai Medical Center

Interventions Increased exercise intensity Placebo Sodium Nitrate Sodium Nitrate - double dose

Updated 6 times since 2017 Last updated: Jan 10, 2020 Started: Oct 31, 2013 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02147639, this PHASE2/PHASE3 trial focuses on Becker Muscular Dystrophy and remains completed. Sponsored by Cedars-Sinai Medical Center, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Feb 2020 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

Status: Unknown Status → Completed
Jun 2018 — Feb 2020 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cedars-Sinai Medical Center

Data source: Cedars-Sinai Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States